Reversal of ER-β silencing by chromatin modifying agents overrides acquired tamoxifen resistance
Year: 2013
Type: article
Source: Cancer Letters
Institution: University of Cyprus
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2029540715
